276 related articles for article (PubMed ID: 21457220)
21. EN3427: a novel cationic aminoindane with long-acting local anesthetic properties.
Banerjee M; Baranwal A; Saha S; Saha A; Priestley T
Anesth Analg; 2015 Apr; 120(4):941-9. PubMed ID: 25695675
[TBL] [Abstract][Full Text] [Related]
22. Co-Application of Eugenol and QX-314 Elicits the Prolonged Blockade of Voltage-Gated Sodium Channels in Nociceptive Trigeminal Ganglion Neurons.
Hwang SM; Lee K; Im ST; Go EJ; Kim YH; Park CK
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33167484
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of inflammatory pain and cough by a novel charged sodium channel blocker.
Tochitsky I; Jo S; Andrews N; Kotoda M; Doyle B; Shim J; Talbot S; Roberson D; Lee J; Haste L; Jordan SM; Levy BD; Bean BP; Woolf CJ
Br J Pharmacol; 2021 Oct; 178(19):3905-3923. PubMed ID: 33988876
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of TRPV channel block on polymodal activation of rat cutaneous nociceptors in vitro.
St Pierre M; Reeh PW; Zimmermann K
Exp Brain Res; 2009 Jun; 196(1):31-44. PubMed ID: 19404626
[TBL] [Abstract][Full Text] [Related]
25. The quaternary lidocaine derivative, QX-314, produces long-lasting local anesthesia in animal models in vivo.
Lim TK; Macleod BA; Ries CR; Schwarz SK
Anesthesiology; 2007 Aug; 107(2):305-11. PubMed ID: 17667576
[TBL] [Abstract][Full Text] [Related]
26. Lighting a backfire to quench the blaze: a combined drug approach targeting the vanilloid receptor TRPV1.
Blumberg PM
Mol Interv; 2007 Dec; 7(6):310-2. PubMed ID: 18199852
[TBL] [Abstract][Full Text] [Related]
27. Systemic QX-314 Reduces Bone Cancer Pain through Selective Inhibition of Transient Receptor Potential Vanilloid Subfamily 1-expressing Primary Afferents in Mice.
Fuseya S; Yamamoto K; Minemura H; Yamaori S; Kawamata T; Kawamata M
Anesthesiology; 2016 Jul; 125(1):204-18. PubMed ID: 27176211
[TBL] [Abstract][Full Text] [Related]
28. QX-314 inhibits acid-induced activation of esophageal nociceptive C fiber neurons.
Hu Y; Yu X; Yu S
Neurogastroenterol Motil; 2019 Apr; 31(4):e13543. PubMed ID: 30663188
[TBL] [Abstract][Full Text] [Related]
29. Characterization of dental nociceptive neurons.
Kim HY; Chung G; Jo HJ; Kim YS; Bae YC; Jung SJ; Kim JS; Oh SB
J Dent Res; 2011 Jun; 90(6):771-6. PubMed ID: 21364091
[TBL] [Abstract][Full Text] [Related]
30. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
[TBL] [Abstract][Full Text] [Related]
31. Multisteric TRPV1 nocisensor: a target for analgesics.
Szolcsányi J; Sándor Z
Trends Pharmacol Sci; 2012 Dec; 33(12):646-55. PubMed ID: 23068431
[TBL] [Abstract][Full Text] [Related]
32. Attenuation of Colitis-Induced Visceral Hypersensitivity and Pain by Selective Silencing of TRPV1-Expressing Fibers in Rat Colon.
Mazor Y; Engelmayer N; Nashashibi H; Rottenfußer L; Lev S; Binshtok AM
Inflamm Bowel Dis; 2024 Mar; ():. PubMed ID: 38478397
[TBL] [Abstract][Full Text] [Related]
33. The quaternary lidocaine derivative QX-314 in combination with bupivacaine for long-lasting nerve block: Efficacy, toxicity, and the optimal formulation in rats.
Yin Q; Li J; Zheng Q; Yang X; Lv R; Ma L; Liu J; Zhu T; Zhang W
PLoS One; 2017; 12(3):e0174421. PubMed ID: 28334014
[TBL] [Abstract][Full Text] [Related]
34. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.
Cui M; Honore P; Zhong C; Gauvin D; Mikusa J; Hernandez G; Chandran P; Gomtsyan A; Brown B; Bayburt EK; Marsh K; Bianchi B; McDonald H; Niforatos W; Neelands TR; Moreland RB; Decker MW; Lee CH; Sullivan JP; Faltynek CR
J Neurosci; 2006 Sep; 26(37):9385-93. PubMed ID: 16971522
[TBL] [Abstract][Full Text] [Related]
35. Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314.
Blake KJ; Baral P; Voisin T; Lubkin A; Pinho-Ribeiro FA; Adams KL; Roberson DP; Ma YC; Otto M; Woolf CJ; Torres VJ; Chiu IM
Nat Commun; 2018 Jan; 9(1):37. PubMed ID: 29295977
[TBL] [Abstract][Full Text] [Related]
36. Novel charged sodium and calcium channel inhibitor active against neurogenic inflammation.
Lee S; Jo S; Talbot S; Zhang HB; Kotoda M; Andrews NA; Puopolo M; Liu PW; Jacquemont T; Pascal M; Heckman LM; Jain A; Lee J; Woolf CJ; Bean BP
Elife; 2019 Nov; 8():. PubMed ID: 31765298
[TBL] [Abstract][Full Text] [Related]
37. QX-314 inhibits ectopic nerve activity associated with neuropathic pain.
Omana-Zapata I; Khabbaz MA; Hunter JC; Bley KR
Brain Res; 1997 Oct; 771(2):228-37. PubMed ID: 9401743
[TBL] [Abstract][Full Text] [Related]
38. QX-314 produces long-lasting local anesthesia modulated by transient receptor potential vanilloid receptors in mice.
Ries CR; Pillai R; Chung CC; Wang JT; MacLeod BA; Schwarz SK
Anesthesiology; 2009 Jul; 111(1):122-6. PubMed ID: 19512885
[TBL] [Abstract][Full Text] [Related]
39. Capsaicin combined with local anesthetics preferentially prolongs sensory/nociceptive block in rat sciatic nerve.
Gerner P; Binshtok AM; Wang CF; Hevelone ND; Bean BP; Woolf CJ; Wang GK
Anesthesiology; 2008 Nov; 109(5):872-8. PubMed ID: 18946300
[TBL] [Abstract][Full Text] [Related]
40. Low potency inhibition of Na
Klasfauseweh T; Israel MR; Ragnarsson L; Cox JJ; Durek T; Carter DA; Leffler A; Vetter I; Deuis JR
Eur J Pharmacol; 2022 Jun; 925():175013. PubMed ID: 35537491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
